Global Biopharmaceutical Drug Delivery Device Technology Market 2018-2023 - Focus on New Innovations

DUBLIN, Dec. 21, 2018 /PRNewswire/ --

The "World Market for Biopharmaceutical Drug Delivery Device Technology" report has been added to ResearchAndMarkets.com's offering.

The total market for biopharmaceutical drug delivery is very complex and shifting due to technological advancements.

Though the market to date has been dominated by injectable administration, injections are not the first choice among patients and compliance is an ongoing issue.

Further, as the majority of new entities in development are biologics requiring advanced drug delivery, manufacturers of devices have been busy developing new innovations that will meet the current needs of biopharmaceuticals already on the market and future biopharmaceuticals in development.

The development of safe, efficient, cost-effective needle-free devices has long been a major goal of the drug delivery community. The technology continues to advance as needle-free company marketers are evolving, searching for a strategy that will achieve commercial success.

Companies have invested in new device models that incorporate design enhancements and improved engineering. The report discusses selected needle-free Injector systems, touching on implants, pumps, microfluidic technology, and transdermal technology.

World Market for Biopharmaceutical Drug Delivery Device Technology examines biopharmaceutical drug delivery technologies currently in development. These include:

• Microsphere Technology
• Targeted Technology
• Intracellular Delivery Technology
• MicroChip Technology
• Protein-Coated Microcrystal Technology
• Needle-Free Delivery Development
• Bolus Injectors
• Large Volume Wearable Injectors
• Combination Products
• Arrayed Microinjectors

Many of the drug development companies have products in development that utilize their proprietary drug delivery systems.

The number of companies providing biopharmaceutical drug delivery platforms continues to proliferate.

The biopharmaceutical drug delivery device industry is comprised of companies seeking to develop novel alternatives to existing delivery systems, enhancements to existing systems, commercially enabling delivery systems that provide viable alternatives for biotherapeutics that are not fully developed and marketed because there are limited practical means of administration.

Key Topics Covered

1. Executive Summary

• Overview
• Market Drivers
• Market Size and Growth
• Table Summary: Total Market Size and Growth for Biopharmaceutical Drug Delivery Device Market, 2018-2023 ($millions)
• Scope and Methodology
• Market Conclusions

2. Introduction

• Biopharmaceutical Overview
• Challenges of Biopharmaceuticals
• Areas of Treatment for Biopharmaceuticals
• Biopharmaceutical Products
• Nanotechnology
• Au Nanoparticles
• Hydrogel Nanoparticles
• Dendrimers
• Other Nanocarriers
• Formulations
• Microparticles
• Nanoparticles
• Depot Injection

3. Biopharmaceuticals: Drug Delivery Technology

• Needle-free Technology
• Auto-Injectors
• Pen Injectors
• Table Selected Needle-free Injector Systems and Manufacturers
• Implants, Pumps, Microfluidic Technology
• Implants
• Implantable and Microfluidic Pumps
• Transdermal Technology
• Microneedles
• Nanopatches

4. Biopharmaceuticals: Alternative Routes of Drug Delivery

• Pulmonary
• Oral
• Targeted/Intracellular
• Table Selected Products Utilizing Microspheres and Nanoparticle Technology
• Table Selected PEGylated Protein Products

5. Trends and Drug Delivery Developments

• Biopharmaceuticals Drug Delivery Development
• Microsphere Technology
• Targeted Technology
• Intracellular Delivery Technology
• MicroChip Technology
• Protein-Coated Microcrystal Technology
• Needle-Free Delivery Development
• Bolus Injectors
• Large Volume Wearable Injectors
• Combination Products
• Arrayed Microinjectors
• Innovative Drug Delivery
• Selected Products in Development
• Table Selected Biopharmaceutical Drug Delivery Technology in Development
• Reimbursement

6. Market Size and Growth

• Total Market
• Table Total Market Size and Growth for Biopharmaceutical Drug Delivery Device Market, 2018-2023 ($millions)
• Market by Technology
• Table Market Size and Growth for Needle-free Biopharmaceutical Drug Delivery Device Market, 2018-2023 ($millions)
• Table Market Size and Growth for Transdermal Biopharmaceutical Drug Delivery Device Market, 2018-2023 ($millions)
• Table Market Size and Growth for Implants, Pumps and Microfluidic Biopharmaceutical Drug Delivery Device Market, 2018-2023 ($millions)
• Table Market Size and Growth for Other Biopharmaceutical Drug Delivery Device Market, 2018-2023 ($millions)
• Table Drug Delivery Device Market by Region 2018 by Percent (%)
• Table Drug Delivery Device Market by Region 2023 by Percent (%)
• Market by Application
• Table Drug Delivery Device Market by Application 2018
• Market by Region
• Table Market Size and Growth for North America Biopharmaceutical Drug Delivery Device Market, 2018-2023 ($millions)
• Table Market Size and Growth for European Biopharmaceutical Drug Delivery Device Market, 2018- 2023 ($millions)
• Table European Biopharmaceutical Drug Delivery Device Market by Country, 2018
• Table Market Size and Growth for Asia Pacific Biopharmaceutical Drug Delivery Device Market, 2018-2023 ($millions)
• Table Asia Pacific Biopharmaceutical Drug Delivery Device Market by Country 2018
• Table Market Size and Growth for RoW Biopharmaceutical Drug Delivery Device Market, 2018-2023 ($millions)
• Table RoW Biopharmaceutical Drug Delivery Device Market by Country, 2018
• Competitive and Market Share
• Competitive Landscape
• Market Analysis

7. Company Profiles

• 3M Pharmaceuticals
• Table 3M Corporate Summary
• Company Overview
• Company Financials
• Table 3M Revenue (2015-2018) ($ millions)
• Adocia
• Table Adocia Corporate Summary
• Company Overview
• Company Financials
• Table Adocia Revenue (2015-2018) ($ millions)
• Alkermes, Inc
• Table Alkermes Corporate Summary
• Company Overview
• Company Financials
• Table Alkermes Revenue (2015-2018) ($ millions)
• Antares Pharma
• Table Antares Pharma Corporate Summary
• Company Overview
• Company Financials
• Table Antares Revenue (2015-2018) ($ millions)
• Ascendis Pharma A/S
• Table Ascendis Pharma Corporate Summary
• Company Overview
• Company Financials
• Becton Dickinson and Company
• Table Becton, Dickinson and Company (BD) Corporate Summary
• Company Overview
• Company Financials
• Table BD Revenue (2015-2018) ($ millions)
• Bespak
• Table Bespak Corporate Summary
• Company Overview
• Catalent Pharma Solutions
• Table Catalent Pharma Corporate Summary
• Company Overview
• Company Financials
• Table Catalent Revenue (2015-2018) ($ millions)
• Credence MedSystems
• Table Credence MedSystems Corporate Summary
• Company Overview
• D'Antonio Consultants International
• Table D'Antonio Consultants Corporate Summary
• Company Overview
• Enable Injections, Inc
• Table Enable Injections Corporate Summary
• Company Overview
• Halozyme Therapeutics, Inc.
• Table Halozyme Therapeutics Corporate Summary
• Company Overview
• Company Financials
• Table Halozyme Revenue (2015-2018) ($ millions)
• InnoCore Pharmaceuticals, Inc.
• Table InnoCore Corporate Summary
• Company Overview
• Inovio Pharmaceuticals, Inc.
• Table Inovio Pharmaceuticals Corporate Summary
• Company Overview
• Company Financials
• Table Inovio Revenue (2015-2018) ($ millions)
• Insulet Corporation
• Table Insulet Corporate Summary
• Company Overview
• Company Financials
• Table Insulet Revenue (2015-2018) ($ millions)
• Intarcia Therapeutics, Inc.
• Table Intarcia Corporate Summary
• Company Overview
• Ligand Pharmaceuticals, Inc.
• Table Ligand Corporate Summary
• Company Overview
• Company Financials
• Table Ligand Revenue (2015-2018) ($ millions)
• Medical International Technologies
• Table Medical International Technologies Corporate Summary
• Company Overview
• Medtronic, Inc.
• Table Medtronic Corporate Summary
• Company Overview
• Company Financials
• Table Medtronic Revenue (2015-2018) ($ millions)
• Micron Biomedical
• Table Micron Biomedical Corporate Summary
• Company Overview
• Mystic Pharmaceuticals
• Table Mystic Pharmaceuticals Corporate Summary
• Company Overview
• Nektar Therapeutics
• Table Nektar Therapeutics Corporate Summary
• Company Overview
• Company Financials
• Table Nektar Revenue (2015-2018) ($ millions)
• Pharmajet, Inc.
• Table Pharmajet Corporate Summary
• Company Overview
• Portal Instruments, Inc.
• Table Portal Instruments Corporate Summary
• Company Overview
• SHL Group
• Table SHL Group Corporate Summary
• Company Overview
• Valeritas, Inc.
• Table Valeritas Corporate Summary
• Company Overview
• Company Financials
• Table Valeritas Revenue (2015-2018) ($ millions)
• West Pharmaceutical Services, Inc.
• Table West Pharmaceutical Corporate Summary
• Company Overview
• Company Financials
• Table West Pharmaceutical Revenue (2015-2018) ($ millions)
• Ypsomed AG
• Table Ypsomed Corporate Summary
• Company Overview

For more information about this report visit https://www.researchandmarkets.com/research/kvbcsm/global?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com